{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T06:36:16Z","timestamp":1759991776017,"version":"build-2065373602"},"reference-count":6,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["M\u00e9decine et Maladies Infectieuses"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1016\/j.medmal.2014.07.003","type":"journal-article","created":{"date-parts":[[2014,8,18]],"date-time":"2014-08-18T23:30:17Z","timestamp":1408404617000},"page":"393-395","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Tol\u00e9rance des antibiotiques utilis\u00e9s par voie orale dans les infections ost\u00e9oarticulaires sur\u00a0mat\u00e9riel \u00e0 staphylocoque"],"prefix":"10.1016","volume":"44","author":[{"given":"E.C.","family":"Ngo Bell","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Forestier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Montbarbon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Ferry-Blanco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.","family":"Rogeaux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.medmal.2014.07.003_bib0005","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/j.medmal.2009.05.004","article-title":"Recommandations de pratique clinique. Infections ost\u00e9oarticulaires sur mat\u00e9riel (proth\u00e8se, implant, ost\u00e9osynth\u00e8se)","volume":"39","year":"2009","journal-title":"Med Mal Infect"},{"year":"2014","series-title":"Proth\u00e8se de hanche ou de genou\u00a0: diagnostic et prise en charge de l\u2019infection dans le mois suivant l\u2019implantation. Recommandation pour la pratique clinique. Rapport de la Haute Autorit\u00e9 de sant\u00e9","key":"10.1016\/j.medmal.2014.07.003_bib0010"},{"issue":"4","key":"10.1016\/j.medmal.2014.07.003_bib0015","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/j.1472-8206.2007.00490.x","article-title":"Lack of association between rifampicin plasma concentration and treatment-related side effects in osteoarticular infections","volume":"21","author":"Roblot","year":"2007","journal-title":"Fundam Clin Pharmacol"},{"issue":"Suppl. 2","key":"10.1016\/j.medmal.2014.07.003_bib0020","first-page":"S3","article-title":"Antibiotics currently used in the treatment of infections caused by Staphylococcus aureus","volume":"35","author":"Rayner","year":"2005","journal-title":"Intern Med J"},{"key":"10.1016\/j.medmal.2014.07.003_bib0025","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1111\/j.1469-0691.2009.02761.x","article-title":"Efficacy and tolerance of rifampicin\u2013linezolid compared with rifampicin\u2013cotrimoxazole combinations in prolonged oral therapy for bone and joint infections","volume":"15","author":"Nguyen","year":"2009","journal-title":"Clin Microbiol Infect"},{"issue":"2","key":"10.1016\/j.medmal.2014.07.003_bib0030","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1128\/AAC.02032-13","article-title":"Antimicrobial -related severe adverse events during treatment of bone and joint infection due to methicillin-susceptible Staphylococcus aureus","volume":"58","author":"Valour","year":"2014","journal-title":"Antimicrob Agents Chemother"}],"container-title":["M\u00e9decine et Maladies Infectieuses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0399077X14001607?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0399077X14001607?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T01:13:16Z","timestamp":1759972396000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0399077X14001607"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8]]},"references-count":6,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["S0399077X14001607"],"URL":"https:\/\/doi.org\/10.1016\/j.medmal.2014.07.003","relation":{},"ISSN":["0399-077X"],"issn-type":[{"type":"print","value":"0399-077X"}],"subject":[],"published":{"date-parts":[[2014,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tol\u00e9rance des antibiotiques utilis\u00e9s par voie orale dans les infections ost\u00e9oarticulaires sur\u00a0mat\u00e9riel \u00e0 staphylocoque","name":"articletitle","label":"Article Title"},{"value":"M\u00e9decine et Maladies Infectieuses","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.medmal.2014.07.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}